Starting at full dose dramatically increases nausea and other GI symptoms
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity), along with tirzepatide (Mounjaro, Zepbound)a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonistare effective medications for type 2 diabetes and weight management
According to the recent findings from Harvard economist Rebecca Diamond in her June 2026 National Bureau of Economic Research working paper, GLP-1Induced Weight Loss and the Female Obesity Penalty, women who were not employed when they began taking GLP-1 medications for weight loss experienced a significant change in their employment prospects after 18 months of usage
The stool sits in your large intestine for hours longer than it normally would
This suggests that TTE endpoints may offer a more reliable approach for assessing disease-modifying therapies in the context of clinical trials on top of standard of care, where symptomatic treatment adjustments may occur